NEOMYCIN SULFATE | A060304 | TEVA PHARMACEUTICALS USA INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Fermenta Animal Health FDA-1992-P-0497 · 7 docket documents Fermenta Animal Health Company submitted a suitability petition under Section 512(n)(3) of the Federal Food, Drug and Cosmetic Act requesting permission to file an abbreviated new animal drug application (ANADA) for NEOVET (Neomycin Sulfate) Bolus, an oral solid dosage form for cattle, swine, sheep | Other | 2017-04-03 | Granted | Fermenta Animal Health |
Citizen Petition from Sparhawk Laboratories, Inc FDA-2006-P-0332 · 4 docket documents Sparhawk Laboratories, Inc. filed this petition on June 19, 2006, to change the dosage form of Neomycin from soluble powder to liquid under NADA 11-315, with supporting data submitted as Neomycin Liquid under ANADA 200-379, and requested categorical exclusion from environmental assessment requiremen | Other | 2009-03-30 | Granted | Sparhawk Laboratories, Inc |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.8579
per ea
Lowest NADAC/Unit
$0.8579
per ea
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00093117701NEOMYCIN 500 MG TABLET | $0.8579 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.